Priming of pancreatic cancer cells with bispecific antibody armed activated T cells sensitizes tumors for enhanced chemoresponsiveness

In this study, we investigated the ability of bispecific antibody armed activated T cells to target drug resistant pancreatic cancer cells and whether or not “priming” these resistant cancer cells with bispecific antibody armed activated T cells could enhance subsequent responsiveness to chemotherap...

Descripción completa

Detalles Bibliográficos
Autores principales: Thakur, Archana, Ung, Johnson, Tomaszewski, Elyse N., Schienschang, Amy, LaBrie, Timothy M., Schalk, Dana L., Lum, Lawrence G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8172155/
https://www.ncbi.nlm.nih.gov/pubmed/34123574
http://dx.doi.org/10.1080/2162402X.2021.1930883

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8172155/
https://www.ncbi.nlm.nih.gov/pubmed/34123574
http://dx.doi.org/10.1080/2162402X.2021.1930883

Ejemplares similares